Zydus' challenge to block Helsinn patent dismissed by Indian court on jurisdiction
Zydus Healthcare’s petition challenging a Helsinn Healthcare patent for an anti-nausea drug was dismissed by an Indian court, citing lack of territorial jurisdiction and no jurisdictional error by the Patent Office.Zydus...To view the full article, register now.
Already a subscriber? Click here to view full article